By Ahmed Aboulenein WASHINGTON (Reuters) – Obstetricians, gynecologists, other medical professionals, and abortion rights advocates petitioned the U.S. Food and Drug Administration (FDA) on Tuesday to urge Danco Laboratories to seek approval of mifepristone, a pill used in terminating early pregnancies at home, for miscarriage management. Danco, one of two U.S. companies that make the medicine, said that right now it has no plans to do so. “At this time, we are not planning to submit (an application) for miscarriage management, but may reconsider in the future,” a spokesperson said. Danco is c…